loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

Technical details about 03C8I9296V, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 88069-49-2, Pilsicainide hcl, N-(2,6-dimethylphenyl)-2-(hexahydro-1h-pyrrolizin-7a-yl)acetamide hydrochloride, Sunrythm, Pilsicainide (hydrochloride), Sun 1165
Molecular Formula
C17H25ClN2O
Molecular Weight
308.8  g/mol
InChI Key
NZOSVDHCTCLGEB-UHFFFAOYSA-N
FDA UNII
03C8I9296V

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-(2,6-dimethylphenyl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)acetamide;hydrochloride
2.1.2 InChI
InChI=1S/C17H24N2O.ClH/c1-13-6-3-7-14(2)16(13)18-15(20)12-17-8-4-10-19(17)11-5-9-17;/h3,6-7H,4-5,8-12H2,1-2H3,(H,18,20);1H
2.1.3 InChI Key
NZOSVDHCTCLGEB-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3.Cl
2.2 Other Identifiers
2.2.1 UNII
03C8I9296V
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1h-pyrrolizine-7a(5h)-acetamide, N-(2,6-dimethylphenyl)tetrahydro-, Hydrochloride (1:1)

2. 1h-pyrrolizine-7a(5h)-acetamide, N-(2,6-dimethylphenyl)tetrahydro-, Hydrochloride Hemihydrate

3. N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide Hydrochloride

4. Pilsicainide

5. Pilsicainide Hydrochloride Hemihydrate

6. Pilsicainide Hydrochloride Hydrate

7. Sun 1165

8. Sun-1165

9. Tetrahydro-1h-pyrrolizine-7a(5h)-aceto-2',6'-xylidide

2.3.2 Depositor-Supplied Synonyms

1. 88069-49-2

2. Pilsicainide Hcl

3. N-(2,6-dimethylphenyl)-2-(hexahydro-1h-pyrrolizin-7a-yl)acetamide Hydrochloride

4. Sunrythm

5. Pilsicainide (hydrochloride)

6. Sun 1165

7. Pilsicainide Hydrochoride

8. Sun 1165; Sunrythm

9. 88069-49-2 (hcl)

10. 03c8i9296v

11. Sun-1165

12. N-(2,6-dimethylphenyl)-2-(tetrahydro-1h-pyrrolizin-7a(5h)-yl)acetamide Hydrochloride

13. N-(2,6-dimethylphenyl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)acetamide;hydrochloride

14. Unii-03c8i9296v

15. Pilsicainide Hydrochloride [jan]

16. N-(2,6-dimethylphenyl)-1h-pyrrolizine-8-acetamide Hydrochloride

17. N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide Monohydrochloride

18. 1h-pyrrolizine-8-acetamide, Hexahydro-n-(2,6-dimethylphenyl)-, Hydrochloride

19. N-(2,6-dimethylphenyl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)acetamide Hydrochloride

20. Schembl483632

21. Chembl4303511

22. Dtxsid7057860

23. Amy8863

24. Bcp09636

25. Mfcd00903769

26. Akos025287418

27. Ds-9555

28. Du-6552

29. 1h-pyrrolizine-7a(5h)-acetamide, N-(2,6-dimethylphenyl)tetrahydro-, Monohydrochloride

30. Pilsicainide Hydrochloride [who-dd]

31. Hy-101245

32. Pilsicainide Hydrochloride, >=98% (hplc)

33. Cs-0021031

34. Ft-0630955

35. P2634

36. 69p492

37. A16362

38. C76901

39. A842458

40. Q27247552

41. 1h-pyrrolizine-7a(5h)-acetamide, N-(2,6-dimethylphenyl)tetrahydro-, Hydrochloride (1:1)

42. N-(2,6-dimethylphenyl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)acetamide,hydrochloride

43. N-(2,6-dimethylphenyl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)ethanamide Hydrochloride

44. N-(2,6-dimethylphenyl)-2-(hexahydro-1h-pyrrolizin-7a-yl)acetamide Hcl

45. N-(2,6-dimethylphenyl)-2-(hexahydro-1h-pyrrolizin-7a-yl)acetamidehydrochloride

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 308.8 g/mol
Molecular Formula C17H25ClN2O
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count3
Exact Mass308.1655411 g/mol
Monoisotopic Mass308.1655411 g/mol
Topological Polar Surface Area32.3 Ų
Heavy Atom Count21
Formal Charge0
Complexity348
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)


Sodium Channel Blockers

A class of drugs that act by inhibition of sodium influx through cell membranes. Blockade of sodium channels slows the rate and amplitude of initial rapid depolarization, reduces cell excitability, and reduces conduction velocity. (See all compounds classified as Sodium Channel Blockers.)


Post Enquiry
POST ENQUIRY